InvestorsHub Logo
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

Re: north40000 post# 487

Friday, 10/04/2019 8:13:54 PM

Friday, October 04, 2019 8:13:54 PM

Post# of 866

Would clinical trials that involve Amarin’s Vascepa and MRK’s drug compositions that include Keytruda or Zocor be “junk science”?

A combination with Zocor might make sense, but Zocor has been off-patent for several years, and MRK no longer has any interest in it.

A trial testing Vascepa in combination with Keytruda would indeed be junk science, in my humble opinion.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News